EXTENDED BENCH
LIVE

Serial Number

99322680

Owner

Sterling Pharma Solutions Limited

Attorney

Laura A. Kees

Filing Date

Aug 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EXTENDED BENCH Trademark

Serial Number: 99322680

EXTENDED BENCH is a trademark filed by Sterling Pharma Solutions Limited on August 6, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Sterling Pharma Solutions Limited (3 trademarks)

Cramlington
Northumberland NE237QG , GB

Entity Type: 99

Trademark Details

Filing Date

August 6, 2025

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Pharmaceutical research services; pharmaceutical development services; pharmaceutical product design services; testing of pharmaceuticals; scientific research in the nature of conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals of others to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; pharmaceutical reports, namely, preparation of reports relating to pharmaceutical research; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Custom manufacturing in the field of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of pharmaceuticals; treatment and disposal being destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services

Chemicals for use in the pharmaceutical industry; active chemical ingredients for use in the manufacture of pharmaceuticals

Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; pharmaceuticals for medical or veterinary purposes, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 9, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 23, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 23, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 23, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 6, 2025 MAFR
NEW APPLICATION ENTERED
Aug 6, 2025 NWAP